Literature DB >> 23411687

Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test.

Yusuke Suzuki1, Kenji Imai, Koji Takai, Tatsunori Hanai, Hideki Hayashi, Takafumi Naiki, Yoichi Nishigaki, Eiichi Tomita, Masahito Shimizu, Hisataka Moriwaki.   

Abstract

PURPOSE: Oxidative stress plays an important role in liver carcinogenesis. To determine the impact of oxidative stress on the recurrence of stage I/II hepatocellular carcinoma (HCC) after curative treatment, we conducted a prospective case series analysis.
METHODS: This study included 45 consecutive patients with stage I/II HCC, who underwent curative treatment by surgical resection or radiofrequency ablation at Gifu Municipal Hospital from 2006 to 2007. In these 45 cases, recurrence-free survival was estimated using the Kaplan-Meier method. The factors contributing to HCC recurrence, including the serum levels of derivatives of reactive oxygen metabolites (d-ROM) as an index of oxidative stress, were subjected to univariate and multivariate analyses using the Cox proportional hazards model.
RESULTS: The serum levels of d-ROM (P = 0.0231), α-fetoprotein (AFP, P = 0.0274), and fasting plasma glucose (P = 0.0400) were significantly associated with HCC recurrence in the univariate analysis. Multivariate analysis showed that the serum levels of d-ROM (hazard ratio [HR] 1.0038, 95 % confidence interval [CI] 1.0002-1.0071, P = 0.0392) and AFP (HR 1.0002, 95 % CI 1.0000-1.0003, P = 0.0316) were independent predictors of HCC recurrence. Kaplan-Meier analysis showed that recurrence-free survival was low in patients with high serum d-ROM (≥570 Carr U, P = 0.0036) and serum AFP (≥40 ng/dL, P = 0.0185) levels.
CONCLUSIONS: The serum levels of d-ROM and AFP can be used for screening patients with a high risk for HCC recurrence. Patients who show increased levels of these factors require careful surveillance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411687     DOI: 10.1007/s00432-013-1389-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  38 in total

Review 1.  Does oxidative stress participate in the development of hepatocellular carcinoma?

Authors:  Yutaka Sasaki
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

2.  Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2.

Authors:  Chi-Tan Hu; Jia-Ru Wu; Chuan-Chu Cheng; Sindy Wang; Hsiao-Ting Wang; Ming-Che Lee; Ling-Jung Wang; Siou-Mei Pan; Tsu-Yao Chang; Wen-Sheng Wu
Journal:  Clin Exp Metastasis       Date:  2011-08-14       Impact factor: 5.150

Review 3.  Dietary antioxidants in the prevention of hepatocarcinogenesis: a review.

Authors:  Howard P Glauert; Karen Calfee-Mason; Divinia N Stemm; Job C Tharappel; Brett T Spear
Journal:  Mol Nutr Food Res       Date:  2010-07       Impact factor: 5.914

Review 4.  Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.

Authors:  Abby B Siegel; Andrew X Zhu
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

5.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis.

Authors:  Toshiharu Sakurai; Guobin He; Atsushi Matsuzawa; Guann-Yi Yu; Shin Maeda; Gary Hardiman; Michael Karin
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

6.  An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease.

Authors:  Cristina Vassalle; Lorenza Pratali; Claudio Boni; Antonella Mercuri; Rudina Ndreu
Journal:  Clin Biochem       Date:  2008-07-26       Impact factor: 3.281

7.  Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.

Authors:  Jin Sil Chung; Sunhoo Park; Seon Ho Park; Eun-Ran Park; Pu-Hyeon Cha; Bu-Yeo Kim; Young Min Chung; Seon Rang Woo; Chul Ju Han; Sang-Bum Kim; Kyung-Suk Suh; Ja-June Jang; Kyoungbun Lee; Dong Wook Choi; Sora Lee; Gi Young Lee; Ki Baik Hahm; Jung Ar Shin; Byung Soo Kim; Kyung Hee Noh; Tae Woo Kim; Kee-Ho Lee; Young Do Yoo
Journal:  Gastroenterology       Date:  2012-06-26       Impact factor: 22.682

8.  Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma.

Authors:  K Ikeda; S Saitoh; A Tsubota; Y Arase; K Chayama; H Kumada; G Watanabe; M Tsurumaru
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

9.  Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C.

Authors:  Sabina Mahmood; Miwa Kawanaka; Ayumi Kamei; Akiyoshi Izumi; Keiichi Nakata; Gouichi Niiyama; Hideji Ikeda; Shinichi Hanano; Mitsuhiko Suehiro; Kazumi Togawa; Gotaro Yamada
Journal:  Antioxid Redox Signal       Date:  2004-02       Impact factor: 8.401

10.  Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment.

Authors:  Naoki Watanabe; Koji Takai; Kenji Imai; Masahito Shimizu; Takafumi Naiki; Masahito Nagaki; Hisataka Moriwaki
Journal:  J Clin Biochem Nutr       Date:  2011-10-29       Impact factor: 3.114

View more
  17 in total

1.  An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.

Authors:  Ying Fu; Shana Silverstein; Justine N McCutcheon; Marcin Dyba; Raghu G Nath; Monika Aggarwal; Heidi Coia; Angela Bai; Jishen Pan; Jiji Jiang; Bhaskar Kallakury; Hongkun Wang; Yu-Wen Zhang; Giuseppe Giaccone; Aiwu Ruth He; Fung-Lung Chung
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

2.  (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis.

Authors:  Takafumi Sumi; Yohei Shirakami; Masahito Shimizu; Takahiro Kochi; Tomohiko Ohno; Masaya Kubota; Makoto Shiraki; Hisashi Tsurumi; Takuji Tanaka; Hisataka Moriwaki
Journal:  Springerplus       Date:  2013-12-27

3.  Preventive effects of the angiotensin-converting enzyme inhibitor, captopril, on the development of azoxymethane-induced colonic preneoplastic lesions in diabetic and hypertensive rats.

Authors:  Takahiro Kochi; Masahito Shimizu; Tomohiko Ohno; Atsushi Baba; Takafumi Sumi; Masaya Kubota; Yohei Shirakami; Hisashi Tsurumi; Takuji Tanaka; Hisataka Moriwaki
Journal:  Oncol Lett       Date:  2014-05-12       Impact factor: 2.967

4.  Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Leonardo Lorente; Sergio T Rodriguez; Pablo Sanz; Pedro Abreu-González; Dácil Díaz; Antonia M Moreno; Elisa Borja; María M Martín; Alejandro Jiménez; Manuel A Barrera
Journal:  Int J Mol Sci       Date:  2016-04-05       Impact factor: 5.923

5.  Serum Reactive Oxygen Metabolite Levels Predict Severe Exacerbations of Asthma.

Authors:  Keitaro Nakamoto; Masato Watanabe; Mitsuru Sada; Toshiya Inui; Masuo Nakamura; Kojiro Honda; Hiroo Wada; Yu Mikami; Hirotaka Matsuzaki; Masafumi Horie; Satoshi Noguchi; Yasuhiro Yamauchi; Hikari Koyama; Toshiyuki Kogane; Tadashi Kohyama; Hajime Takizawa
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

6.  P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients.

Authors:  Janielle P Maynard; Ju-Seog Lee; Bo Hwa Sohn; Xiaoying Yu; Dolores Lopez-Terrada; Milton J Finegold; John A Goss; Sundararajah Thevananther
Journal:  Oncotarget       Date:  2015-12-01

Review 7.  Disease monitoring of hepatocellular carcinoma through metabolomics.

Authors:  Asem I Fitian; Roniel Cabrera
Journal:  World J Hepatol       Date:  2017-01-08

8.  Enhanced development of azoxymethane-induced colonic preneoplastic lesions in hypertensive rats.

Authors:  Takahiro Kochi; Masahito Shimizu; Tomohiko Ohno; Atsushi Baba; Takafumi Sumi; Masaya Kubota; Yohei Shirakami; Hisashi Tsurumi; Takuji Tanaka; Hisataka Moriwaki
Journal:  Int J Mol Sci       Date:  2013-07-15       Impact factor: 5.923

Review 9.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

10.  Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma.

Authors:  Kenji Imai; Koji Takai; Tatsunori Hanai; Makoto Shiraki; Yusuke Suzuki; Hideki Hayashi; Takafumi Naiki; Youichi Nishigaki; Eiichi Tomita; Masahito Shimizu; Hisataka Moriwaki
Journal:  Int J Mol Sci       Date:  2014-06-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.